These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 736702)

  • 1. Reversal of adenine-induced depression of mouse locomotor activity by amphetamine.
    Akintonwa A; Auditore JV
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):248-53. PubMed ID: 736702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 3. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
    Messiha FS
    Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse.
    Bradbury AJ; Costall B; Naylor RJ; Onaivi ES
    Psychopharmacology (Berl); 1987; 93(4):457-65. PubMed ID: 3124179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
    Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
    Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice.
    Karper PE; De la Rosa H; Newman ER; Krall CM; Nazarian A; McDougall SA; Crawford CA
    Psychopharmacology (Berl); 2002 Feb; 159(4):407-14. PubMed ID: 11823893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice.
    Hanania T; Zahniser NR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):431-40. PubMed ID: 11981117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between locomotor activity changes produced by phencyclidine and D-amphetamine in CD-1 male mice.
    Stavchansky S; Riffee W; Geary R
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):189-202. PubMed ID: 4023408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of kinins on amphetamine activity.
    Moniuszko-Jakoniuk J; Kościelak M
    Pol J Pharmacol Pharm; 1976; 28(6):661-5. PubMed ID: 1012987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
    Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
    J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of benzodiazepines on brain amines of the mouse.
    Fennessy MR; Lee JR
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):37-44. PubMed ID: 5031577
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased sensitivity to d- and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity.
    Lucki I; Harvey JA
    Neuropharmacology; 1979 Mar; 18(3):243-9. PubMed ID: 571542
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice.
    Villégier AS; Salomon L; Blanc G; Godeheu G; Glowinski J; Tassin JP
    Eur J Neurosci; 2006 Sep; 24(5):1359-65. PubMed ID: 16965547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
    Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
    Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.